Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer

BACKGROUND: Risk of normal tissue toxicity limits the amount of thoracic radiation therapy (RT) that can be routinely prescribed to treat non-small cell lung cancer (NSCLC). An early biomarker of response to thoracic RT may provide a way to predict eventual toxicities—such as radiation pneumonitis—d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Radiat Oncol
Autors principals: Dinh, Tru-Khang T., Fendler, Wojciech, Chałubińska-Fendler, Justyna, Acharya, Sanket S., O’Leary, Colin, Deraska, Peter V., D’Andrea, Alan D., Chowdhury, Dipanjan, Kozono, David
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847218/
https://ncbi.nlm.nih.gov/pubmed/27117590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-016-0636-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars